Can-Fite begins Phase II trials for dry eye treatment - Globes
January 28, 2007| Can-Fite begins Phase II trials for dry eye treatment Globes, Israel - Can-Fite originally developed CF101 as a cancer treatment, and later extended its effectiveness for treating rheumatoid arthritis. ... |
Pharma Sector: Few Newsmakers Of The Week - Pfizer, Merck, Coley ... - Trading Markets
January 28, 2007| Pharma Sector: Few Newsmakers Of The Week - Pfizer, Merck, Coley ... Trading Markets, CA - Methtrxate, the standard treatment for rheumatoid arthritis is found to be more beneficial when used in combination rather than used as a monotherapy. ... Genentech's Next Act |